News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab’s (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions
NCI investigators have developed a solution to address the challenges that nucleic acid based therapeutics face of non-specific delivery and degradation of the nanoparticles. NCI’s solution is an inducible activation nucleic acid hybrid switch. The use of nucleic acid logic elements in these
The National Institute of Standards and Technology (NIST) has published a report, written by David P. Leech and John T. Scott, titled Federal Agency Return on Investment in Foreign Patenting. This report details the U.S. federal agencies’ use of foreign patents to protect their intellectual property